In the Pipeline

Metformin Against Cancer?

It’s always good to hear about an older compound that may be doing good things that we didn’t realize.

Read the full story

Posted in In the PipelineComments (0)

Posters and Pickiness

Blogging time is short today, since I’m on a deadline to produce a couple of posters for presentation. These are for an internal hoe-down, unfortunately, so I won’t be able to share the fruits of my labors with everyone out there in the readership. With any luck, though, they’ll turn into public presentations/publications eventually, though

Read the full story

Posted in In the PipelineComments (0)

How Long Would It Take - If Everything Worked?

Over at BoingBoing, they’re investigating the question: “How long would your PhD have taken if everything worked the first time ?” I have to admit, it took me a few minutes to adjust my head to that idea, since God knows, nothing in my PhD ever looked like working the first time. And it’s a hard one to answer, because I had to do some backtracking, as so often happens in total synthesis. This was of the “Dang it all, turns out I can’t install that carbon at that step, so I’m going to have to go back, put it in earlier, and hope the downstream stuff still works” variety

Read the full story

Posted in In the PipelineComments (0)

Scientia Est Experentia

Chad Orzel has a post up on the two halves of physics, and about how people tend to forget one of them: the experimentalists. I think he’s right, and the problem is the glamorous coating that began to stick to theoretical physics in the early 20th century (and has never completely flaked away)

Read the full story

Posted in In the PipelineComments (0)

Scientia Est Experientia

Chad Orzel has a post up on the two halves of physics, and about how people tend to forget one of them: the experimentalists. I think he’s right, and the problem is the glamorous coating that began to stick to theoretical physics in the early 20th century (and has never completely flaked away). Several things led to that split: the startling predictions of relativity and quantum mechanics, borne out by experimentalists right down to the most unlikely-sounding results, for one.

Read the full story

Posted in In the PipelineComments (0)

Nanopowders?

Here’s a lab question for everyone. I have a bottle of Aldrich copper oxide nanopowder on my lab bench; I’ve been meaning to try it out for some Ullmann reactions. I note that Aldrich (and others) are now selling a variety of such nanopowders, mostly metals and insoluble metal compounds.

Read the full story

Posted in In the PipelineComments (0)

Avastin For Metastatic Breast Cancer: The Whole Story

Here’s an excellent roundup of the Avastin story, referenced in an earlier post here . I have to say, I’ve been disappointed in some of the commentary on this issue (which that article goes into as well).

Read the full story

Posted in In the PipelineComments (0)

Roche: Layoffs, or Rumors?

A Swiss newspaper reported over the weekend that Roche is planning large cuts, across much of their multinational organization. Here’s the original article , for those of you who read German

Read the full story

Posted in In the PipelineComments (0)

How About The Same Price You Turned Down Before? Hmm?

Well, so much for my fantasy of Sanofi-Aventis walking away from their attempt to buy Genzyme. They went public yesterday with a $69/share offer - even lower than most people were thinking - and just a little while ago, Genzyme publicly turned them down . What’s more, this is apparently the same price at which Genzyme (privately) balked earlier in the summer.

Read the full story

Posted in In the PipelineComments (0)

Not Your Usual FDA Hearing

You always had to wonder how the move of appointing Sidney Wolfe to the Drugs Safety and Risks Management Committee at the FDA was going to work out. The signs of friction are appearing

Read the full story

Posted in In the PipelineComments (0)


Ask Our Experts

Dawn Obermoeller

Dawn Obermoeller
Social Media

Jonathan Richman

Jonathan Richman
Non-Personal Promotion

Optimize RX

Optimize RX
Internet Marketing & Analytics

Share Your Knowledge

We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.

  • Popular
  • Latest
  • Comments
  • Tags
  • Subscribe

Site Sponsored by

Interested in sponsoring on this site? Please click here.

Vendor Ratings

If you have had a positive experience with a pharmaceutical vendor, and would like to recommend that they be added to our vendor database, please click here.